Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 471,884 | 382,805 | 177,519 | 115,516 | 102,520 |
| Marketable Securities | 364,074 | 180,599 | 187,193 | 274,101 | 226,512 |
| TOTAL | $849,572 | $578,761 | $377,541 | $402,995 | $337,720 |
| Non-Current Assets | |||||
| PPE Net | 16,948 | 16,311 | 16,238 | 16,308 | 15,448 |
| Investments And Advances | 0 | 0 | 6,139 | 24,290 | 0 |
| Intangibles | 50,881 | 52,019 | 52,325 | 52,631 | 52,936 |
| Other Non-Current Assets | 25,858 | 25,147 | 24,871 | 15,847 | 16,538 |
| TOTAL | $93,687 | $93,477 | $99,573 | $109,076 | $84,922 |
| Total Assets | $943,259 | $672,238 | $477,114 | $512,071 | $422,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,796 | 4,382 | 18,768 | 5,881 | 5,815 |
| Accrued Expenses | 44,339 | 38,560 | 21,918 | 26,495 | 22,953 |
| Other current liabilities | 20,300 | 4,700 | 10,700 | 20,649 | 6,726 |
| TOTAL | $76,998 | $54,940 | $56,396 | $59,206 | $44,316 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,563 | 7,298 | 5,010 | 6,181 | 8,822 |
| Other Non-Current Liabilities | 46,786 | 46,399 | 30,518 | 12,948 | 647,410 |
| TOTAL | $53,906 | $53,519 | $40,385 | $28,923 | $659,123 |
| Total Liabilities | $130,904 | $108,459 | $96,781 | $88,129 | $703,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,389 | 127,055 | 117,902 | 109,800 | 109,679 |
| Common Shares | 13 | 12 | 11 | 11 | 1 |
| Retained earnings | -561,535 | -476,926 | -445,759 | -368,519 | -304,748 |
| Other shareholders' equity | -485 | -295 | 248 | -601 | 81 |
| TOTAL | $812,355 | $563,779 | $380,333 | $423,942 | $-280,797 |
| Total Liabilities And Equity | $943,259 | $672,238 | $477,114 | $512,071 | $422,642 |